FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294818100> ?p ?o ?g. }

• W4294818100 endingPage "563" @default.
• W4294818100 startingPage "563" @default.
• W4294818100 abstract "FacioScapuloHumeral Dystrophy (FSHD) effects around 1:15,000 people; making it the third most common type of muscular dystrophy worldwide. Gait is becoming a possible marker of disease progression however this may vary by the type of FSHD. It is important to understand if a relationship exists between the epigenetics status at the FSHD pathogenic locus and gait. PURPOSE: The purpose of this study is to measure the relationship between gait and DNA methylation percentage in 4A allele FSDH type 1 patients. METHODS: 5 participants (2 males; 3 females; 58 ± 15 years) who were diagnosed clinically and genetically with 4A allele (FSHD 1) were recruited for the study. All participants were mailed a smart-phone (LG KG40) loaded with our custom Gait Analyzer application, a belt for holding the phone, instructions, and a saliva testing kit. All participants completed 12 consecutive ten-meter walking trials with a 3-second pause over a flat level surface between trials for 5 days straight. Participants used the custom application to rate fatigue pre- and post-gait trials and take pictures of their shoes and walking surface. Upon return, gait data were further analyzed controlling for shoe type and walking surface. In addition, saliva samples were bisulfite converted, and assayed using our FSHD epigenetic analysis to determine the DNA methylation of the shortest 4q35 D4Z4 array (DRA: D4Z4 reduced allele). Spearman rho correlation coefficients determined the relationship between methylation percentage, gait velocity, and cadence after controlling for walking surface and shoe type. RESULTS: A strong positive relationship between methylation percentage and gait velocity (average = 0.92 ± 0.19 m/s; r = 0.74, p < 0.05) with a moderate negative relationship to cadence (average = 88.78 ± 8.8 steps/min; r = -0.42, p < 0.5) was observed. CONCLUSIONS: These results suggest that methylation percentage of the 4q35 D4Z4 distal repeat region in FSHD type 1 patients is related to gait impairments. Low methylation status in FSHD type 1 patients is associated with greater gait impairments. The findings of this study should be expanded to other forms of FSHD and muscular dystrophy but may serve as a candidate clinical outcome measure for future clinical trials." @default.
• W4294818100 created "2022-09-06" @default.
• W4294818100 creator A5010232240 @default.
• W4294818100 creator A5011609203 @default.
• W4294818100 creator A5016799299 @default.
• W4294818100 creator A5029197305 @default.
• W4294818100 creator A5062412292 @default.
• W4294818100 creator A5073510329 @default.
• W4294818100 creator A5082649134 @default.
• W4294818100 creator A5084647800 @default.
• W4294818100 creator A5084947238 @default.
• W4294818100 date "2022-09-01" @default.
• W4294818100 modified "2023-09-27" @default.
• W4294818100 title "Methylation Percentage Among FSHD Type 1 Relates To Gait Impairment Analyzed Using Custom Gait Application" @default.
• W4294818100 doi "https://doi.org/10.1249/01.mss.0000882124.66338.85" @default.
• W4294818100 hasPublicationYear "2022" @default.
• W4294818100 type Work @default.
• W4294818100 citedByCount "0" @default.
• W4294818100 crossrefType "journal-article" @default.
• W4294818100 hasAuthorship W4294818100A5010232240 @default.
• W4294818100 hasAuthorship W4294818100A5011609203 @default.
• W4294818100 hasAuthorship W4294818100A5016799299 @default.
• W4294818100 hasAuthorship W4294818100A5029197305 @default.
• W4294818100 hasAuthorship W4294818100A5062412292 @default.
• W4294818100 hasAuthorship W4294818100A5073510329 @default.
• W4294818100 hasAuthorship W4294818100A5082649134 @default.
• W4294818100 hasAuthorship W4294818100A5084647800 @default.
• W4294818100 hasAuthorship W4294818100A5084947238 @default.
• W4294818100 hasBestOaLocation W42948181001 @default.
• W4294818100 hasConcept C104317684 @default.
• W4294818100 hasConcept C150194340 @default.
• W4294818100 hasConcept C151800584 @default.
• W4294818100 hasConcept C173906292 @default.
• W4294818100 hasConcept C1862650 @default.
• W4294818100 hasConcept C190727270 @default.
• W4294818100 hasConcept C54355233 @default.
• W4294818100 hasConcept C71924100 @default.
• W4294818100 hasConcept C86803240 @default.
• W4294818100 hasConcept C99508421 @default.
• W4294818100 hasConceptScore W4294818100C104317684 @default.
• W4294818100 hasConceptScore W4294818100C150194340 @default.
• W4294818100 hasConceptScore W4294818100C151800584 @default.
• W4294818100 hasConceptScore W4294818100C173906292 @default.
• W4294818100 hasConceptScore W4294818100C1862650 @default.
• W4294818100 hasConceptScore W4294818100C190727270 @default.
• W4294818100 hasConceptScore W4294818100C54355233 @default.
• W4294818100 hasConceptScore W4294818100C71924100 @default.
• W4294818100 hasConceptScore W4294818100C86803240 @default.
• W4294818100 hasConceptScore W4294818100C99508421 @default.
• W4294818100 hasIssue "9S" @default.
• W4294818100 hasLocation W42948181001 @default.
• W4294818100 hasLocation W42948181002 @default.
• W4294818100 hasOpenAccess W4294818100 @default.
• W4294818100 hasPrimaryLocation W42948181001 @default.
• W4294818100 hasRelatedWork W1954924192 @default.
• W4294818100 hasRelatedWork W2026283600 @default.
• W4294818100 hasRelatedWork W2077522866 @default.
• W4294818100 hasRelatedWork W2093541729 @default.
• W4294818100 hasRelatedWork W2096286708 @default.
• W4294818100 hasRelatedWork W2166173325 @default.
• W4294818100 hasRelatedWork W2566432776 @default.
• W4294818100 hasRelatedWork W2839643714 @default.
• W4294818100 hasRelatedWork W3029047068 @default.
• W4294818100 hasRelatedWork W4372349982 @default.
• W4294818100 hasVolume "54" @default.
• W4294818100 isParatext "false" @default.
• W4294818100 isRetracted "false" @default.
• W4294818100 workType "article" @default.